Skip to main content
Clinical Trials/NCT00768625
NCT00768625
Unknown
Not Applicable

Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea

Associacao Fundo de Incentivo a Psicofarmcologia1 site in 1 country2,000 target enrollmentApril 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obstructive Sleep Apnea
Sponsor
Associacao Fundo de Incentivo a Psicofarmcologia
Enrollment
2000
Locations
1
Primary Endpoint
Cardiovascular events
Last Updated
17 years ago

Overview

Brief Summary

The purpose of this study is:

  1. To determine the frequency of cardiovascular diseases in patients with OSA, obese, overweight, and lean (BMI<25)
  2. To analyze the CPAP treatment over the clinical evolution of OSA patients
  3. To determine if OSA is a independent predictor of cardiovascular risk

Detailed Description

Obstructive Sleep Apnea (OSA) is a condition with important cardiovascular repercussions. However, the association between OSA, cardiovascular diseases, and obesity has not been totally clarified. We hypothesized that the cardiovascular consequences of OSA are due to obesity.

Registry
clinicaltrials.gov
Start Date
April 2005
End Date
December 2012
Last Updated
17 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Associacao Fundo de Incentivo a Psicofarmcologia

Eligibility Criteria

Inclusion Criteria

  • Men and women with OSA (apnea-hypopnea index higher than 5 events/hour)

Exclusion Criteria

  • Body mass index higher than 40

Outcomes

Primary Outcomes

Cardiovascular events

Time Frame: five years

Study Sites (1)

Loading locations...

Similar Trials